| Madeleine Logan, | |
|
150-50 14th Road, Whitestone, NY 11357 | |
| (718) 767-0091 | |
| Not Available |
| Full Name | Madeleine Logan |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 150-50 14th Road, Whitestone, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013482157 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Madeleine Logan, 150-50 14th Road, Whitestone, NY 11357 Ph: () - | Madeleine Logan, 150-50 14th Road, Whitestone, NY 11357 Ph: (718) 767-0091 |
News Archive
Personalized post cards or phone calls can be effective in encouraging more seniors to get their annual flu shots, according to a new review of evidence. Professional facilitators are also successful at urging providers to perform a suite of preventive services, including flu shots for seniors.
Three months after undergoing renal denervation —a procedure that delivers energy to overactive nerves leading to the kidney to decrease their activity—patients with untreated high blood pressure had statistically significant reductions in average blood pressure over 24 hours compared with patients who underwent a sham procedure and experienced no major adverse effects, according to results from the SPYRAL-HTN OFF MED pivotal trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
A workshop on "Neuroeconomics and Endocrinological Economics," to be held Nov. 20 and 21 at UC Davis, will be the first to bring together experts in neuroscience, economics and hormone physiology in one event, according to organizers.
Diamyd Medical AB, to date no drug related Serious Adverse Events have been reported by any patient included in Diamyd's Phase I clinical trial investigating NP2 as a potential therapy for chronic pain. Based upon the Phase I findings to date, the company is planning a multi-center, randomized, double-blind, placebo controlled Phase II clinical trial with NP2 in the United States.
› Verified 5 days ago
Ms. Keovmorkodh Kucharski, M.S. CF-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 150-50 14th Road, Whitestone, NY 11357 Phone: 718-767-0091 Fax: 718-767-0086 | |
All In 1 Spot With Theratalk Slp, Pt, Ot, Psychology Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0091 | |
Natasha Eva Kriegel, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 516-784-8966 | |
Ms. Julianna Maria Ioannou, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0091 Fax: 718-767-0086 | |
Mrs. Despina Katsiaris, MS CCC-SLP, TSSLD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0091 Fax: 718-767-0086 | |
Katherine Werbeck, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0071 |